| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 Mar 25 | MDGL Madrigal Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 3,784 | 0.00 | 10,698 |
| 5 Mar 25 | MDGL Madrigal Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 347.28 | 6,374 | 2.21 mm | 6,374 |
| 3 Mar 25 | MDGL Madrigal Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 323.5357 | 774 | 250.42 k | 6,914 |
| 3 Mar 25 | MDGL Madrigal Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 325.89 | 1,187 | 386.83 k | 7,688 |
| 2 Jan 25 | ORIC ORIC Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 8.26 | 35,000 | 289.10 k | 35,000 |
| 14 Jun 24 | PRLD Prelude Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 3.9 | 23,500 | 91.65 k | 23,500 |
| 12 Jun 24 | ORIC ORIC Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 7.9 | 25,600 | 202.24 k | 25,600 |
